SCHEMBL17994142

SCHEMBL17994142

OCCc1csc2c(N3CCCCCC3)nc(Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.46
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
SLC29A1 Q99808 9/20 0.35
ALDH1A1 P00352 3/20 0.35
PDE4A P27815 3/20 0.35
PDE4B Q07343 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
PDE2A O00408 1/20 0.35
RGS12 O14924 1/20 0.35
SLC22A2 O15244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937267 0.88 HTR2C (0.44) HTR2CNPC1SLC29A1SMN1; SMN2KDM4E
SCHEMBL4248606 0.72 HTR2C (0.43) HTR2CNPC1SMN1; SMN2KDM4EMAPT
SCHEMBL5315250 0.68 ALDH1A1 (0.46) SLC29A1ALDH1A1PDE4APDE4BPDE4C
SCHEMBL7930957 0.66 ALDH1A1 (0.44) SLC29A1ALDH1A1PDE4APDE4BPDE4C
SCHEMBL7942147 0.65 HTT (0.45) NPC1PKMSLC29A1ALDH1A1PDE4A
SCHEMBL1284337 0.65 PIK3CA (0.46) HTR2CNPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL5055246 0.64 SLC29A1 (0.43) SLC29A1ALDH1A1PDE4APDE4BPDE4C
SCHEMBL5055250 0.64 SLC29A1 (0.83) SLC29A1ALDH1A1PDE4APDE4BPDE4C
SCHEMBL4439753 0.64 HTR2C (0.45) HTR2CNPC1SMN1; SMN2KDM4E
SCHEMBL29973070 0.64 SLC29A1 (0.83) SLC29A1ALDH1A1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3053925-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2016-08-10 EP disclosed